Assembly Biosciences(ASMB)
搜索文档
Assembly Biosciences, Inc. (ASMB) CEO on Hepatitis B Program Update Call Transcript
2021-03-01 05:57
Assembly Biosciences, Inc. (NASDAQ:ASMB) Hepatitis B Program Update Conference Call February 25, 2021 5:00 PM ET Company Participants Lauren Glaser - Senior Vice President of Investor Relations and Corporate Affairs John McHutchison - President and Chief Executive Officer Bill Delaney - Chief Scientific Officer Luisa Stamm - Chief Medical Officer Conference Call Participants Brian Skorney - Baird Raju Prasad - William Blair Michael Yee - Jefferies Geoffrey Porges - SVB Leerink Salim Syed - Mizuho Nicole Ger ...
Assembly Biosciences(ASMB) - 2020 Q3 - Quarterly Report
2020-11-06 06:14
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to___________. Commission file number: 001-35005 ASSEMBLY BIOSCIENCES, INC. (Exact name of Registrant as specified in its charter) Delaware 20-8729264 (St ...
Assembly Biosciences(ASMB) - 2020 Q2 - Quarterly Report
2020-08-06 04:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to___________. Commission file number: 001-35005 ASSEMBLY BIOSCIENCES, INC. (Exact name of Registrant as specified in its charter) Delaware 20-8729264 (State o ...
Assembly Biosciences, Inc. (ASMB) Assembly Biosciences' HBV Portfolio Progress Conference Call (Transcript)
2020-05-13 10:51
Assembly Biosciences, Inc. (NASDAQ:ASMB) Assembly Biosciences’ HBV Portfolio Progress Conference Call May 7, 2020 4:30 PM ET Company Participants Amy Figueroa - Interim Investor Relations Consultant Dr. John McHutchison - CEO and President Dr. Luisa Stamm - CMO Tom Russo - CFO Richard Colonno - EVP and CSO Virology Operations Conference Call Participants Brian Skorney - Baird Brad Canino - SVB Leerink Michael Yee - Jefferies Salim Syed - Mizuho Raju Prasad - William Blair Operator Good afternoon and welcome ...
Assembly Biosciences(ASMB) - 2020 Q1 - Quarterly Report
2020-05-09 04:13
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to___________. Commission file number: 001-35005 ASSEMBLY BIOSCIENCES, INC. (Exact name of Registrant as specified in its charter) Delaware 20-8729264 (State ...
Assembly Biosciences(ASMB) - 2019 Q4 - Annual Report
2020-03-05 05:32
SecuritiesRegisteredPursuant TitleofEachClass Stock,$0.001ParValue UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from __________ to __________ Commission File Number: 001-35005 ASSEMBLY BIOSCIENCES, INC. (Exact name of registra ...